PMV Pharmaceuticals, Inc.
PMVP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001699382
No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding PMV Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 105 | +8 |
| Shares | 55.2M | 50.8K | 61.1M | +5.93M (+10.7%) |
| Value | $1.15B | $1.06M | $870.9M | −$278.1M (−24.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (25)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (17)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Cowen and Company, LLC | 1,261,529 | $26.3M |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,076,000 | $22.4M |
| Healthcare of Ontario Pension Plan Trust Fund | 781,600 | $16.3M |
| EcoR1 Capital, LLC | 649,786 | $13.5M |
| Jennison Associates LLC | 303,641 | $6.32M |
| Norges Bank | 238,200 | $4.96M |
| Commodore Capital LP | 125,000 | $2.60M |
| Prudential Financial Inc | 50,825 | $1.06M |
| Integral Health Asset Management, LLC | 50,000 | $1.04M |
| Two Sigma Investments, LP | 44,900 | $935.0K |
| Fred Alger Management, LLC | 36,868 | $768.0K |
| Two Sigma Advisers, LP | 28,100 | $585.0K |
| Blueshift Asset Management, LLC | 13,635 | $284.0K |
| ProShare Advisors LLC | 9,614 | $200.0K |
| Nisa Investment Advisors, LLC | 1,200 | $25.0K |
| Deerfield Management Company, L.P. (Series C) | 470 | $10.0K |
| M&R Capital Management Inc | 5 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held PMV Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 46,528 | $969.0K |
| Amalgamated Financial Corp. | 4,271 | $89.0K |